Article

Warburg Pincus acquires B&L

Warburg Pincus has completed its acquisition of Bausch & Lomb (B&L) for a total purchase price of approximately $4.5 billion, including nearly $830 million of debt.

Rochester, NY-Warburg Pincus has completed its acquisition of Bausch & Lomb (B&L) for a total purchase price of approximately $4.5 billion, including nearly $830 million of debt.

"With a strong and supportive partner in Warburg Pincus, we are well positioned to create new opportunities for Bausch & Lomb and advance our leadership in the eye health industry," said Ronald L. Zarrella, chairman and chief executive officer of B&L.

Elizabeth H. Weatherman, a Warburg Pincus managing director, said, "We're delighted to be partners with B&L. We look forward to helping the company build upon its rich heritage and premier brand in ophthalmology."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
© 2025 MJH Life Sciences

All rights reserved.